Market breadth remained decisively positive, with 2,457 stocks advancing 843 stocks declining, reflecting strong participation across the broader market. On the sectoral front, PSU banks, realty, financial services, auto, and pharma emerged as key outperformers, each rising more than 2%, while FMCG was the only notable laggard. Midcap and healthcare counters also witnessed healthy buying interest, indicating sustained risk appetite beyond frontline names.
